XML 40 R8.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES      
Net income $ 1,250 $ 2,027  
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 544 559  
Amortization of right of use lease asset 88 0  
Accretion related to acquisition, net (20) (81)  
Provision for loan losses 300 226 $ 318
Gain on sale of securities, net 0 (26)  
Net amortization of securities 154 335  
Increase in loans held for sale, net (1,719) (170)  
Net (gain) on sale of other real estate owned 0 (2)  
Income from bank owned life insurance (231) (192)  
Stock compensation expense 86 50  
Deferred tax benefit 215 589  
Increase in other assets (573) (595)  
Decrease in accrued expenses and other liabilities (1,426) (1,067)  
Net cash (used in) provided by operating activities (1,332) 1,653  
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchases of available-for-sale securities (13,570) (19,141)  
(Purchases of) proceeds from redemption restricted securities, net (226) 162  
Proceeds from maturities and calls of available-for-sale securities 2,500 2,150  
Proceeds from sales of available-for-sale securities 0 6,476  
Paydowns on available-for-sale securities 3,459 2,583  
Net (increase) decrease in loans held for investment (12,850) 10,926  
Proceeds from sales of other real estate owned 0 85  
Purchases of premises and equipment (368) (498)  
Net cash (used in) provided by investing activities (21,055) 2,743  
CASH FLOWS FROM FINANCING ACTIVITIES      
Decrease in noninterest-bearing deposits (4,454) (13,311)  
Increase in savings deposits 29,816 4,274  
(Decrease) increase in time deposits (12,322) 2,109  
Decrease in federal funds purchased, repurchase agreements and other borrowings, net (6,785) (1,282)  
Increase in Federal Home Loan Bank advances 25,000 5,000  
Repayment of Federal Home Loan Bank advances (20,000) (10,000)  
Proceeds from ESPP issuance 21 19  
Cash dividends paid on common stock (624) (623)  
Net cash provided by (used in) financing activities 10,652 (13,814)  
Net decrease in cash and cash equivalents (11,735) (9,418)  
Cash and cash equivalents at beginning of period 89,865 42,217 42,217
Cash and cash equivalents at end of period 78,130 32,799 $ 89,865
Cash payments for:      
Interest 1,639 1,486  
SUPPLEMENTAL SCHEDULE OF NONCASH TRANSACTIONS      
Unrealized gain (loss) on securities available-for-sale (563) 1,949  
Loans transferred to other real estate owned 236 0  
Right of use lease asset and liability $ 672 $ 751